Nightingale Health Oyj (HEL:HEALTH)
0.8580
+0.0340 (4.13%)
At close: Jul 27, 2026
Nightingale Health Oyj Balance Sheet
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 42.81 | 41.29 | 43.65 | 80.64 | 95.28 | 113.81 |
Short-Term Investments | - | 9.92 | 22.39 | - | - | - |
Cash & Short-Term Investments | 42.81 | 51.21 | 66.04 | 80.64 | 95.28 | 113.81 |
Cash Growth | -16.39% | -22.46% | -18.11% | -15.36% | -16.28% | 12472.43% |
Accounts Receivable | 2.22 | 1.67 | 1.7 | 0.82 | 1.4 | 0.03 |
Other Receivables | - | - | - | - | - | 0.16 |
Total Trade Receivables | 2.22 | 1.67 | 1.7 | 0.82 | 1.4 | 0.18 |
Inventory | 1.88 | 1.74 | 0.7 | 0.55 | 0.59 | 0.66 |
Other Current Assets | - | - | - | - | - | 0.55 |
Total Current Assets | 46.91 | 54.62 | 68.44 | 82.01 | 97.27 | 116.03 |
Net Property, Plant & Equipment | 11.7 | 10.1 | 8.6 | 7.22 | 7.78 | 0.72 |
Other Intangible Assets | 6.95 | 8.28 | 12.31 | 16.04 | 16.25 | 14.11 |
Goodwill | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | - |
Long-Term Investments | - | 0 | 0.04 | 0.07 | 1.31 | 3.33 |
Other Long-Term Assets | 0.46 | 0.49 | 0.44 | 0.43 | 0.42 | 0.83 |
Total Assets | 67.04 | 74.51 | 90.84 | 106.79 | 124.05 | 134.19 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 3.57 | 3.94 | 4.28 | 3.39 | 3.42 | 0.91 |
Accrued Expenses | - | - | - | - | - | 1.58 |
Current Portion of Long-Term Debt | - | 0.26 | 0.57 | 1.38 | 2.07 | 1.86 |
Current Portion of Leases | 1.35 | 1.18 | 1.09 | 0.97 | 1.12 | - |
Unearned Revenue | 0.58 | 0.83 | 1.02 | 1.02 | 1.3 | 1.94 |
Other Current Liabilities | - | - | - | - | - | 0.27 |
Total Current Liabilities | 5.5 | 6.21 | 6.95 | 6.76 | 7.92 | 6.56 |
Long-Term Debt | - | - | 0.26 | 1.28 | 2.63 | 3.2 |
Long-Term Leases | 3.54 | 2.12 | 0.72 | 1.41 | 2.06 | - |
Other Long-Term Liabilities | 0.02 | 0.02 | 0.02 | - | - | - |
Total Long-Term Liabilities | 3.56 | 2.14 | 1.01 | 2.68 | 4.69 | 3.2 |
Total Liabilities | 9.06 | 8.35 | 7.96 | 9.44 | 12.61 | 9.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.01 |
Additional Paid-in Capital | 142.41 | 142.41 | 142.38 | 142.38 | 142.38 | 146.38 |
Accumulated Other Comprehensive Income | 0.25 | 0.17 | 0.15 | 0.09 | 0.04 | 0.01 |
Retained Earnings | -84.75 | -76.49 | -59.73 | -45.19 | -31.06 | -22.04 |
Shareholders' Equity | 57.99 | 66.17 | 82.88 | 97.36 | 111.44 | 124.43 |
Total Liabilities & Equity | 67.04 | 74.51 | 90.84 | 106.79 | 124.05 | 134.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 4.89 | 3.57 | 2.64 | 5.03 | 7.88 | 5.06 |
Net Cash (Debt) | 37.93 | 47.64 | 63.4 | 75.61 | 87.4 | 108.75 |
Net Cash Growth | -20.39% | -24.86% | -16.15% | -13.49% | -19.63% | - |
Net Cash Per Share | 0.62 | 0.79 | 1.05 | 1.25 | 1.45 | 2.61 |
Book Value | 57.99 | 66.17 | 82.88 | 97.36 | 111.44 | 124.43 |
Book Value Per Share | 0.95 | 1.10 | 1.37 | 1.61 | 1.85 | 2.99 |
Tangible Book Value | 50.02 | 56.86 | 69.55 | 80.3 | 94.17 | 110.32 |
Tangible Book Value Per Share | 0.82 | 0.94 | 1.15 | 1.33 | 1.56 | 2.65 |